About 422 million people worldwide have diabetes, and 1.5 million deaths are directly attributed to diabetes each year, according to the World Health Organization. Type 1 diabetes is a chronic condition in which the insulin-producing ...
Jun 14, 2022
0
73
Blood vessels are the body's essential architecture that exists in order to nurture cells with sufficient nutrients and oxygen. Angiogenesis, or the formation of new blood vessels, is of great research interest in cancer ...
Jun 13, 2022
0
52
Pancreatic cancers recycle resources to fuel their survival and growth, opening up the possibility of new treatments aimed at stopping them from doing so, scientists report.
May 6, 2022
0
65
One way exercise can counter the damage of diabetes is by enabling activation of a natural system we have to grow new blood vessels when existing ones are ravaged by this disease, scientists report.
Apr 26, 2022
0
212
Many patients recover from COVID within a week or two, but at least one in five experience persistent or new symptoms more than four weeks after first being diagnosed.
Apr 13, 2022
0
23
If the blood supply to your brain decreases, it can trigger Alzheimer's disease. Scientists at UiO wanted to find out whether this leads to more or fewer blood vessels and what role one particular protein plays in such a ...
Mar 29, 2022
1
97
For more than a century, pathologists have classified and graded brain tumors, examining samples under a microscope and looking for telltale signs of tumor class and biological aggressiveness such as cell morphology, cell ...
Mar 22, 2022
0
2
A new therapeutic strategy for hepatocellular cancer (HCC) that initially primes the tumor with an immune checkpoint inhibitor before using a multikinase inhibitor drug showed great promise for treating patients with the ...
Mar 16, 2022
0
45
Insufficient oxygen to an area like the heart or legs, called hypoxia, is a cue to our bodies to make more blood vessels, and scientists have found some unusual partners are key to making that happen.
Mar 8, 2022
0
27
A new study led by researchers at Yale Cancer Center and the University of Maryland Comprehensive Cancer Center shows ixabepilone plus bevacizumab (IXA+BEV) is a well-tolerated, effective combination for treatment of platinum/taxane-resistant ...
Feb 14, 2022
0
19
